- Home
- NMI vs OM Comparison
NMI vs OM Comparison
Compare NMI & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$4.06
Company Overview
Basic Information| Metric | NMI | OM |
|---|---|---|
| Founded | 1988 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.1M | 85.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NMI | OM |
|---|---|---|
| Price | $9.95 | $4.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 28.4K | ★ 579.6K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 4.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,069,000.00 |
| Revenue This Year | N/A | $5.77 |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $8.30 | $4.00 |
| 52 Week High | $10.05 | $25.35 |
Technical Indicators
Market Signals| Indicator | NMI | OM |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 24.63 |
| Support Level | $9.95 | $4.07 |
| Resistance Level | $10.15 | $4.63 |
| Average True Range (ATR) | 0.07 | 0.32 |
| MACD | -0.00 | 0.31 |
| Stochastic Oscillator | 33.33 | 3.61 |
Price Performance
Historical Comparison NMI
OM
About NMI Nuveen Municipal Income Fund Inc.
Nuveen Municipal Income Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.